Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Pediatrix Medical Group ( (MD) ).
On July 1, 2025, Pediatrix Medical Group appointed Dr. Kurt Newman as an independent director. Dr. Newman, a prominent figure in pediatric healthcare and former CEO of Children’s National Hospital, brings extensive clinical insight and leadership experience to the board. His appointment is expected to enhance Pediatrix’s focus on patient-centered care and strengthen collaboration between physicians and executive leadership, contributing to the company’s mission of advancing clinical excellence.
The most recent analyst rating on (MD) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Pediatrix Medical Group stock, see the MD Stock Forecast page.
Spark’s Take on MD Stock
According to Spark, TipRanks’ AI Analyst, MD is a Neutral.
The overall stock score of 64 reflects a cautiously optimistic outlook led by strong earnings call performance, evidenced by same-unit revenue growth and cost management success. Financial performance shows stability in cash flow and balance sheet, despite revenue and profitability challenges. Technical analysis suggests a neutral stance, while the negative valuation metrics pose significant risks.
To see Spark’s full report on MD stock, click here.
More about Pediatrix Medical Group
Pediatrix Medical Group, Inc. is a leading provider of physician services, specializing in obstetrics, maternal-fetal medicine, neonatology, and various pediatric subspecialties. Founded in 1979, the company offers coordinated, compassionate, and clinically excellent services to women, babies, and children in hospital and office-based settings, supported by significant investments in research, education, and quality-improvement initiatives.
Average Trading Volume: 878,985
Technical Sentiment Signal: Buy
Current Market Cap: $1.21B
For a thorough assessment of MD stock, go to TipRanks’ Stock Analysis page.